Literature DB >> 4693654

Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

E J Ruley, J Forristal, N C Davis, C Andres, C D West.   

Abstract

Membranoproliferative nephritis in children is frequently associated with a hypocomplementemia produced at least in part by C3 breakdown mediated by a circulating anticomplementary factor known as C3 nephritic factor (C3NeF). C3 breakdown by this factor in vitro requires the presence of a pseudoglobulin cofactor and magnesium. The present study provides evidence that properdin factor B (C3 proactivator) is activated in the nephritic factor reaction and is the direct mediator of C3 breakdown by C3NeF. Depletion of factor B from mixtures of normal human serum (NHS) and plasma from a patient with membranoproliferative nephritis (MPP), either by heating or by immune equivalence absorption, blocks C3 breakdown by C3NeF. Addition of purified factor B to these mixtures restores the anticomplementary effect. When purified factor B is added to mixtures of MPP and purified C3, breakdown also occurs. Associated with the C3 breakdown is a change in the electrophoretic mobility of factor B from the beta to the gamma position, a shift which has been associated with cleavage activation of the molecule. Further, serum factor B levels are often low in patients with membranoproliferative nephritis and bear a rough inverse correlation with C3NeF levels. It thus appears that factor B is the previously described heat-labile C3NeF cofactor. Whether the C3NeF reaction proceeds via a pathway comparable to that activated by the cobra venom factor or via that activated by zymosan or inulin cannot be determined from the present data.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4693654      PMCID: PMC302337          DOI: 10.1172/JCI107254

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.

Authors:  J F Soothill
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

2.  Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; N C Davis
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

3.  Serum C'3 lytic system in patients with glomerulonephritis.

Authors:  R E Spitzer; E H Vallota; J Forristal; E Sudora; A Stitzel; N C Davis; C D West
Journal:  Science       Date:  1969-04-25       Impact factor: 47.728

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Decreased properdin activity in acute glomerulonephritis.

Authors:  H Gewurz; R J Pickering; G Naff; R Snyderman; S E Mergenhagen; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

6.  Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; J M McConville; N C Davis
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

7.  In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors:  L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

8.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  20 in total

1.  Changes in humoral components of host defense following burn trauma.

Authors:  A B Bjornson; W A Altemeier; H S Bjornson
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

2.  Heterogeneity of nephritic factor and its identification as an immunoglobulin.

Authors:  A E Davis; J B Ziegler; E W Gelfand; F S Rosen; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

Review 3.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

4.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

Review 5.  Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.

Authors:  Andrew S Bomback; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

6.  Serum complement levels before and after the onset of acute post-streptococcal glomerulonephritis. A case report.

Authors:  C F Strife; T J Forristal; J Forristal
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Partial H (beta 1H) deficiency and glomerulonephritis in two families.

Authors:  R J Wyatt; B A Julian; A Weinstein; N F Rothfield; R H McLean
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Reduction in alternative complement pathway mediated C3 conversion following burn injury.

Authors:  A B Bjornson; H S Bjornson; W A Altemeier
Journal:  Ann Surg       Date:  1981-08       Impact factor: 12.969

9.  Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.

Authors:  A B Bjornson; H S Bjornson; B P Kitko
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.

Authors:  A B Bjornson; H S Bjornson; B P Kitko
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.